Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said. The post Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More…
“We’re going to post that, all the prices for everything,” Health and Human Services Secretary Robert F. Kennedy Jr. declared at a recent event held by the conservative Heritage Foundation in Washington. It’s a bold-sounding promise, and a familiar one; politicians from both parties have been repeating it for years now. Both Trump administrations — and the Biden administration in between — have taken whacks at making medical prices more accessible,…
Congress passed a continuing resolution last week that extended expiring Medicare telehealth flexibilities through the next six months. Telehealth CEOs view the passing of the resolution as a short-term win, but they think there is still more work to do to ensure Americans have permanent access to virtual care services in the future. The post…
Other key concerns include reduced access to rural healthcare and emergency department boarding contributing to worse patient outcomes
You can provide the best care possible inside the four walls of your hospital, but if your patients can’t afford their prescriptions after you discharge them, the system isn’t working. The post The Cost of Medication Non-Adherence — How Hospitals Can Close the Gap through Better Communication appeared first on MedCity News.
KalVista Pharmaceuticals brings to Chiesi Group the product Ekterly, the first FDA-approved oral drug for acute treatment of swelling attacks from the rare disease hereditary angioedema. Ekterly’s tablet formulation offers a dosing edge compared to injectable HAE medications. The post Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition appeared first on MedCity…
For patients, recalls can fail to protect them — not because they came too late, but because they stop at notification and never fully translate into action. The post When Recalls Fail — The Gap Between Notification and Action appeared first on MedCity News.
GREENVILLE, Miss. — Cedric Sturdevant woke up with “a bit of depression” but made it to church, as he does every Sunday. In a few days, he would drive from Mississippi to Washington, D.C., to join HIV advocates at an April rally against the Trump administration’s actions. It had clawed back more than $11 billion…
Patients at the five CommonSpirit hospitals in Utah will have access to the physicians and providers at University of Utah Health
Between 4.6 million and 5.2 million adults would lose Medicaid coverage in 2026 due to proposed work requirements, according to a new report. The post What Is the Economic Impact of Medicaid Work Requirements? appeared first on MedCity News.